-DOCSTART- -X- O
Coronaviruses -X- _ B-Patient
( -X- _ I-Patient
CoVs -X- _ I-Patient
) -X- _ I-Patient
are -X- _ O
single-stranded -X- _ O
RNA -X- _ O
viruses -X- _ O
which -X- _ O
contain -X- _ O
the -X- _ O
largest -X- _ O
RNA -X- _ O
genomes -X- _ O
, -X- _ O
and -X- _ O
severe -X- _ O
acute -X- _ O
respiratory -X- _ O
syndrome -X- _ O
coronavirus -X- _ O
( -X- _ O
SARS-CoV -X- _ O
) -X- _ O
, -X- _ O
a -X- _ O
newly -X- _ O
found -X- _ O
group -X- _ O
2 -X- _ O
CoV -X- _ O
, -X- _ O
emerged -X- _ O
as -X- _ O
infectious -X- _ O
disease -X- _ O
with -X- _ O
high -X- _ O
mortality -X- _ O
rate. -X- _ O
In -X- _ O
this -X- _ O
study -X- _ O
, -X- _ O
we -X- _ O
compared -X- _ O
the -X- _ O
synonymous -X- _ B-Intervention
codon -X- _ I-Intervention
usage -X- _ I-Intervention
patterns -X- _ I-Intervention
between -X- _ I-Intervention
the -X- _ I-Intervention
nucleocapsid -X- _ I-Intervention
and -X- _ O
spike -X- _ B-Comparison
genes -X- _ I-Comparison
of -X- _ O
CoVs -X- _ B-Patient
, -X- _ O
and -X- _ O
C- -X- _ B-Intervention
type -X- _ I-Intervention
lectin -X- _ I-Intervention
domain -X- _ I-Intervention
( -X- _ I-Intervention
CTLD -X- _ I-Intervention
) -X- _ I-Intervention
genes -X- _ I-Intervention
of -X- _ O
human -X- _ B-Patient
and -X- _ O
mouse -X- _ B-Comparison
on -X- _ O
the -X- _ O
codon -X- _ O
basis. -X- _ O
Findings -X- _ B-Outcome
indicate -X- _ I-Outcome
that -X- _ I-Outcome
the -X- _ I-Outcome
nucleocapsid -X- _ I-Outcome
genes -X- _ I-Outcome
of -X- _ I-Outcome
CoVs -X- _ I-Outcome
were -X- _ I-Outcome
affected -X- _ I-Outcome
from -X- _ I-Outcome
the -X- _ I-Outcome
synonymous -X- _ I-Outcome
codon -X- _ I-Outcome
usage -X- _ I-Outcome
bias -X- _ I-Outcome
than -X- _ I-Outcome
spike -X- _ I-Outcome
genes -X- _ I-Outcome
, -X- _ I-Outcome
and -X- _ I-Outcome
the -X- _ I-Outcome
CTLDs -X- _ I-Outcome
of -X- _ I-Outcome
human -X- _ I-Outcome
and -X- _ I-Outcome
mouse -X- _ I-Outcome
partially -X- _ I-Outcome
overlapped -X- _ I-Outcome
with -X- _ I-Outcome
the -X- _ I-Outcome
nucleocapsid -X- _ I-Outcome
genes -X- _ I-Outcome
of -X- _ I-Outcome
CoVs. -X- _ I-Outcome
In -X- _ O
addition -X- _ O
, -X- _ O
we -X- _ O
observed -X- _ O
that -X- _ O
CTLDs -X- _ B-Outcome
which -X- _ I-Outcome
showed -X- _ I-Outcome
the -X- _ I-Outcome
similar -X- _ I-Outcome
relative -X- _ I-Outcome
synonymous -X- _ I-Outcome
codon -X- _ I-Outcome
usage -X- _ I-Outcome
( -X- _ I-Outcome
RSCU -X- _ I-Outcome
) -X- _ I-Outcome
patterns -X- _ I-Outcome
with -X- _ I-Outcome
CoVs -X- _ I-Outcome
were -X- _ I-Outcome
commonly -X- _ I-Outcome
derived -X- _ I-Outcome
from -X- _ I-Outcome
the -X- _ I-Outcome
human -X- _ I-Outcome
chromosome -X- _ I-Outcome
12 -X- _ I-Outcome
, -X- _ I-Outcome
and -X- _ I-Outcome
mouse -X- _ I-Outcome
chromosome -X- _ I-Outcome
6 -X- _ I-Outcome
and -X- _ I-Outcome
12 -X- _ I-Outcome
, -X- _ O
suggesting -X- _ O
that -X- _ O
there -X- _ O
might -X- _ O
be -X- _ O
a -X- _ O
specific -X- _ O
genomic -X- _ O
region -X- _ O
or -X- _ O
chromosomes -X- _ O
which -X- _ O
show -X- _ O
a -X- _ O
more -X- _ O
similar -X- _ O
synonymous -X- _ O
codon -X- _ O
usage -X- _ O
pattern -X- _ O
with -X- _ O
viral -X- _ O
genes. -X- _ O
Our -X- _ O
findings -X- _ O
contribute -X- _ O
to -X- _ O
developing -X- _ O
the -X- _ O
codon-optimization -X- _ O
method -X- _ O
in -X- _ O
DNA -X- _ O
vaccines -X- _ O
, -X- _ O
and -X- _ O
further -X- _ O
study -X- _ O
is -X- _ O
needed -X- _ O
to -X- _ O
determine -X- _ O
a -X- _ O
specific -X- _ O
correlation -X- _ O
between -X- _ O
the -X- _ O
codon -X- _ O
usage -X- _ O
patterns -X- _ O
and -X- _ O
the -X- _ O
chromosomal -X- _ O
locations -X- _ O
in -X- _ O
higher -X- _ O
organisms -X- _ O
. -X- _ O

